Am J Surg
- FUNG MHM, Ng WI, Lee HE, Chan TH, et al
The role of artificial intelligence in surgeon-performed ultrasonographic
evaluation of cytologically indeterminate thyroid nodules.
Am J Surg. 2025;249:116599.
Ann Surg
- RAFTERY NB, Elliott JA, Muldoon C, Ryan C, et al
Tackling Prevention and Early Diagnosis of Esophageal Adenocarcinoma Through a
National Barrett's Registry and Scientific Network.
Ann Surg. 2025;282:742-749.
- SMYTH E, O'Neill LM, Kearney N, Sheill G, et al
Preoperative Exercise to Improve Fitness in Patients Undergoing Complex Surgery
for Cancer of the Lung or Esophagus (PRE-HIIT): A Randomized Controlled Trial.
Ann Surg. 2025;282:690-698.
BMC Cancer
- MA H, Wei W, Zhang J, Liang L, et al
Multi-channel deep learning radiomics model based on contrast-enhanced CT for
predicting postoperative prognosis in laryngeal carcinoma.
BMC Cancer. 2025;25:1597.
- ABOOSHAHAB R, Zarkesh M, Hedayati M
Metabolomics fingerprinting of thyroid malignancies: a GC/MS-based approach for
subtype classification and biomarker discovery.
BMC Cancer. 2025;25:1586.
- LIU X, Luo X, Xian Y, Ying L, et al
Fertility, gonadal and sexual function in survivors of nasopharyngeal carcinoma
patients.
BMC Cancer. 2025;25:1583.
- XIE R, Tang X, Lin T, Xiao G, et al
The occurrence of hyperthyroidism after thermal ablation for thyroid papillary
carcinoma: a retrospective multicentre observational study.
BMC Cancer. 2025;25:1587.
- MENG S, Lv A, Li N, Ding X, et al
Global, regional, and national burden of lip and oral cavity cancer and
projections to 2036.
BMC Cancer. 2025;25:1573.
- GU F, Wu E, Yan X, Huang W, et al
AHSA1 as a prognostic biomarker and potential immunotherapeutic target in HNSCC:
integrative bulk RNA-seq, scRNA-seq analyses and experimental validation.
BMC Cancer. 2025;25:1560.
- JANG HB, Kim SA, Jung EK, Lee KH, et al
SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse
xenograft model of head and neck squamous cell carcinoma.
BMC Cancer. 2025;25:1570.
- GROVER P, Tang C, Jacques A, Kernutt E, et al
A two-phase study investigating the quality of life benefit of additional 0.5%
cocaine mouthwash to institutional standard of care mucositis management in head
and neck cancer patients undergoing radiotherapy or chemoradiotherapy.
BMC Cancer. 2025;25:1551.
Br J Cancer
- PAN KF, Chou HL, Wang WL, Chen BR, et al
KSRP-mediated Wnt/beta-catenin activation promotes follicular thyroid cancer
progression and stemness.
Br J Cancer. 2025;133:1111-1121.
Dis Esophagus
- FARNQVIST K, Malberg K, Johnsson SI, Johar A, et al
Health-related quality of life in esophageal cancer: a state-of-the-art review of
patient-reported outcomes and an evidence and gap map.
Dis Esophagus. 2025;38:doaf086.
- COLE K, Gossage JA, Bhandari P, Blencowe NS, et al
Impact of staging investigations on nodal upstaging in early esophago-gastric
adenocarcinoma: multicenter CONGRESS dataset analysis.
Dis Esophagus. 2025;38:doaf085.
Head Neck
- CALABRESE L, Abousiam M, Tagliabue M, Ferrari M, et al
When Should Elective Neck Dissection Be Considered for Early-Stage Oral Cavity
Tumors? Insights From a Multicenter Study of 1109 Patients and Development of a
Multiparametric Predictive Model.
Head Neck. 2025 Oct 13. doi: 10.1002/hed.70064.
- CARLOS M CE, Antoine M, Didier D, Aina B, et al
A Risk-Adapted Approach for Elective Neck Dissection in Salvage Total
Laryngectomy: Revisiting the Role of Tumor Subsite and Occult Nodal Disease.
Head Neck. 2025 Oct 13. doi: 10.1002/hed.70072.
- FROWEN JJ, Drosdowsky A, Fua TF, McDowell LJ, et al
Patient-Reported Dysphagia and Swallowing-Related Quality of Life up to 10 Years
After (Chemo)radiotherapy for Head and Neck Cancer: A Cross-Sectional Study.
Head Neck. 2025 Oct 13. doi: 10.1002/hed.70065.
- KHADELA A, Parikh R, Vaghela J, Chauhan Y, et al
A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the
Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the
Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer
Patients.
Head Neck. 2025 Oct 17. doi: 10.1002/hed.70077.
Int J Cancer
- HAN W, Gao L, Wang X, Li C, et al
Simultaneous integrated boost intensity-modulated radiotherapy with or without
concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A
multicenter, open-label, randomized, phase III clinical trial.
Int J Cancer. 2025 Oct 15. doi: 10.1002/ijc.70176.
Int J Radiat Oncol Biol Phys
- OBERTOPP N, Bekker RA, Grass GD, Zelenka T, et al
Local Single-Dose Radiation Improves Adoptive Cell Therapy With
Tumor-Infiltrating Lymphocytes.
Int J Radiat Oncol Biol Phys. 2025;123:1102-1115.
- SHAH KD, Chamseddine I, Yuan X, Tian S, et al
Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer
Using Bayesian Networks and Markov Blankets.
Int J Radiat Oncol Biol Phys. 2025 Oct 11:S0360-3016(25)06336.
J Clin Endocrinol Metab
- VAN DER MEEREN MMD, Boers T, de Graaf P, Duvivier KM, et al
Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a
learning curve and predictors of success.
J Clin Endocrinol Metab. 2025 Jan 29:dgaf058. doi: 10.1210.
- AEKKA A, Arva NC, Ren HZ, Raval M, et al
Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the
Evaluation of Pediatric Thyroid Nodules.
J Clin Endocrinol Metab. 2025 Mar 4:dgaf110. doi: 10.1210.
- CASALINI R, Romei C, Bottici V, Cappagli V, et al
Prevalence and genetics of "de novo" MEN2 syndromes.
J Clin Endocrinol Metab. 2025;110:e3559-e3565.
Laryngoscope
- PAPADOPOULOU AM, Matsopoulos GK, Kouloulias V, Kyrodimos E, et al
The Application of Radiomics in Laryngeal Cancer Management: A Scoping Review of
the Literature.
Laryngoscope. 2025 Oct 16. doi: 10.1002/lary.70197.
Oral Oncol
- JEYARAJ G
Commentary on "Uncovering chromatin factor landscapes in head and neck squamous
cell carcinoma".
Oral Oncol. 2025 Oct 10:107741. doi: 10.1016/j.oraloncology.2025.107741.
- HONG MH, Lee S, Kim CG, Son W, et al
A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy
followed by surgery in patients with locally advanced head and neck squamous cell
carcinoma.
Oral Oncol. 2025;170:107745.
- BOIDE A, Glasmacher AR, Wurschi G, Tews AM, et al
Fear of cancer recurrence in adults with p16-positive head and neck cancer after
radiotherapy - Results from a multicenter cross-sectional observational study.
Oral Oncol. 2025;170:107757.
PLoS One
- DONG L, Chen L, Qi X, Lu Q, et al
IGF2BP2 contributes to thyroid cancer progression by enhancing the stability of
m6A-modified CTSH mRNA.
PLoS One. 2025;20:e0332061.
- NING X, Wang R, Ogilvie J, Dinauer C, et al
Evaluation of disparities in the incidence, presentation, and treatment of
pediatric differentiated thyroid cancer in the United States (2000-2022).
PLoS One. 2025;20:e0333401.
- QIAN J, Qi S, Hu R, Zhang M, et al
Trends in the disease burden of thyroid cancer among adolescents and young
adults: A comparative study of China and global estimates (1990-2021).
PLoS One. 2025;20:e0333373.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016